...
首页> 外文期刊>Journal of Medicinal Chemistry >1-(2-((5-Cyanopyridin-2-yl)amino)ethylamino)acetyl-2-(S)-pyrrolidinecarbon itrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties.
【24h】

1-(2-((5-Cyanopyridin-2-yl)amino)ethylamino)acetyl-2-(S)-pyrrolidinecarbon itrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties.

机译:1-(2-((5-氰基吡啶-2-基)氨基)乙基氨基)乙酰基-2-(S)-吡咯烷碳不溶性:具有降血糖特性的有效,选择性和口服生物可用的二肽基肽酶IV抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

Dipeptidyl peptidase IV (DPP-IV) inhibition has the potential to become a valuable therapy for type 2 diabetes. We report the first use of solid-phase synthesis in the discovery of a new DPP-IV inhibitor class and a solution-phase synthesis that is practical up to the multikilogram scale. One compound, NVP-DPP728 (2), is profiled as a potent, selective, and short-acting DPP-IV inhibitor that has excellent oral bioavailability and potent antihyperglycemic activity.
机译:抑制二肽基肽酶IV(DPP-IV)可能成为2型糖尿病的有价值的治疗方法。我们报告了在新的DPP-IV抑制剂类的发现中和固相合成的首次使用,以及直至多千克规模的实用的溶液相合成。一种化合物NVP-DPP728(2)被描述为有效,选择性和短效的DPP-IV抑制剂,具有出色的口服生物利用度和有效的降血糖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号